Propafenon (Rytmonorm) által kiváltott tartós pitvarlebegés.

Translated title of the contribution: Persistent atrial flutter induced by propafenone (Rytmonorm)

T. Fazekas, J. Kiss, I. Pap, L. Rudas

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The case history of two patients with atrial fibrillation are presented. In order to prevent/terminate fibrillation propafenone (Rytmonorm, 450-600 mg/day) was started, however this therapy resulted in permanent atrial flutter of 230-270/min mainly with 2:1 antrioventricular conduction. Analyzing the cases the authors emphasize that although Class Ic antiarrhythmic drugs (flecainide, encainide, propafenone) are capable to prevent or terminate atrial fibrillation, they may also induce atrial flutter in approximately 3.5-5% of these patients. The mechanism and recognition of this atrial proarrhythmic action are discussed.

Original languageHungarian
Pages (from-to)1819-1822
Number of pages4
JournalOrvosi Hetilap
Volume135
Issue number33
Publication statusPublished - Aug 14 1994

Fingerprint

Propafenone
Atrial Flutter
Atrial Fibrillation
Encainide
Flecainide
Anti-Arrhythmia Agents
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Fazekas, T., Kiss, J., Pap, I., & Rudas, L. (1994). Propafenon (Rytmonorm) által kiváltott tartós pitvarlebegés. Orvosi Hetilap, 135(33), 1819-1822.

Propafenon (Rytmonorm) által kiváltott tartós pitvarlebegés. / Fazekas, T.; Kiss, J.; Pap, I.; Rudas, L.

In: Orvosi Hetilap, Vol. 135, No. 33, 14.08.1994, p. 1819-1822.

Research output: Contribution to journalArticle

Fazekas, T, Kiss, J, Pap, I & Rudas, L 1994, 'Propafenon (Rytmonorm) által kiváltott tartós pitvarlebegés.', Orvosi Hetilap, vol. 135, no. 33, pp. 1819-1822.
Fazekas T, Kiss J, Pap I, Rudas L. Propafenon (Rytmonorm) által kiváltott tartós pitvarlebegés. Orvosi Hetilap. 1994 Aug 14;135(33):1819-1822.
Fazekas, T. ; Kiss, J. ; Pap, I. ; Rudas, L. / Propafenon (Rytmonorm) által kiváltott tartós pitvarlebegés. In: Orvosi Hetilap. 1994 ; Vol. 135, No. 33. pp. 1819-1822.
@article{322df9c5f5764abe85359924626d8e43,
title = "Propafenon (Rytmonorm) {\'a}ltal kiv{\'a}ltott tart{\'o}s pitvarlebeg{\'e}s.",
abstract = "The case history of two patients with atrial fibrillation are presented. In order to prevent/terminate fibrillation propafenone (Rytmonorm, 450-600 mg/day) was started, however this therapy resulted in permanent atrial flutter of 230-270/min mainly with 2:1 antrioventricular conduction. Analyzing the cases the authors emphasize that although Class Ic antiarrhythmic drugs (flecainide, encainide, propafenone) are capable to prevent or terminate atrial fibrillation, they may also induce atrial flutter in approximately 3.5-5{\%} of these patients. The mechanism and recognition of this atrial proarrhythmic action are discussed.",
author = "T. Fazekas and J. Kiss and I. Pap and L. Rudas",
year = "1994",
month = "8",
day = "14",
language = "Hungarian",
volume = "135",
pages = "1819--1822",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "33",

}

TY - JOUR

T1 - Propafenon (Rytmonorm) által kiváltott tartós pitvarlebegés.

AU - Fazekas, T.

AU - Kiss, J.

AU - Pap, I.

AU - Rudas, L.

PY - 1994/8/14

Y1 - 1994/8/14

N2 - The case history of two patients with atrial fibrillation are presented. In order to prevent/terminate fibrillation propafenone (Rytmonorm, 450-600 mg/day) was started, however this therapy resulted in permanent atrial flutter of 230-270/min mainly with 2:1 antrioventricular conduction. Analyzing the cases the authors emphasize that although Class Ic antiarrhythmic drugs (flecainide, encainide, propafenone) are capable to prevent or terminate atrial fibrillation, they may also induce atrial flutter in approximately 3.5-5% of these patients. The mechanism and recognition of this atrial proarrhythmic action are discussed.

AB - The case history of two patients with atrial fibrillation are presented. In order to prevent/terminate fibrillation propafenone (Rytmonorm, 450-600 mg/day) was started, however this therapy resulted in permanent atrial flutter of 230-270/min mainly with 2:1 antrioventricular conduction. Analyzing the cases the authors emphasize that although Class Ic antiarrhythmic drugs (flecainide, encainide, propafenone) are capable to prevent or terminate atrial fibrillation, they may also induce atrial flutter in approximately 3.5-5% of these patients. The mechanism and recognition of this atrial proarrhythmic action are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0028772549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028772549&partnerID=8YFLogxK

M3 - Article

VL - 135

SP - 1819

EP - 1822

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 33

ER -